Literature DB >> 31941373

An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition.

Jason D Roberts1, S Yukiko Asaki2, Andrea Mazzanti3,4, J Martijn Bos, Izabela Tuleta4,5, Alison R Muir6, Lia Crotti4,7,8,9, Andrew D Krahn10, Valentina Kutyifa11, M Benjamin Shoemaker12,13, Christopher L Johnsrude14, Takeshi Aiba15, Luciana Marcondes16, Anwar Baban4,17, Sharmila Udupa18, Brynn Dechert19, Peter Fischbach20, Linda M Knight20, Eric Vittinghoff21, Deni Kukavica3,4, Birgit Stallmeyer4,22, John R Giudicessi12, Carla Spazzolini4,7, Keiko Shimamoto15, Rafik Tadros23, Julia Cadrin-Tourigny23, Henry J Duff24, Christopher S Simpson25, Thomas M Roston10, Yanushi D Wijeyeratne4,26, Imane El Hajjaji1, Maisoon D Yousif1, Lorne J Gula1, Peter Leong-Sit1, Nikhil Chavali13, Andrew P Landstrom27, Gregory M Marcus28, Sven Dittmann4,22, Arthur A M Wilde4,28, Elijah R Behr4,26, Jacob Tfelt-Hansen4,29, Melvin M Scheinman30, Marco V Perez31, Juan Pablo Kaski4,32, Robert M Gow18, Fabrizio Drago4,17, Peter F Aziz33, Dominic J Abrams34, Michael H Gollob35, Jonathan R Skinner16, Wataru Shimizu15,36, Elizabeth S Kaufman37, Dan M Roden13,38,39, Wojciech Zareba11, Peter J Schwartz4,7, Eric Schulze-Bahr4,22, Susan P Etheridge2, Silvia G Priori3,4, Michael J Ackerman12.   

Abstract

BACKGROUND: Insight into type 5 long QT syndrome (LQT5) has been limited to case reports and small family series. Improved understanding of the clinical phenotype and genetic features associated with rare KCNE1 variants implicated in LQT5 was sought through an international multicenter collaboration.
METHODS: Patients with either presumed autosomal dominant LQT5 (N = 229) or the recessive Type 2 Jervell and Lange-Nielsen syndrome (N = 19) were enrolled from 22 genetic arrhythmia clinics and 4 registries from 9 countries. KCNE1 variants were evaluated for ECG penetrance (defined as QTc >460 ms on presenting ECG) and genotype-phenotype segregation. Multivariable Cox regression was used to compare the associations between clinical and genetic variables with a composite primary outcome of definite arrhythmic events, including appropriate implantable cardioverter-defibrillator shocks, aborted cardiac arrest, and sudden cardiac death.
RESULTS: A total of 32 distinct KCNE1 rare variants were identified in 89 probands and 140 genotype positive family members with presumed LQT5 and an additional 19 Type 2 Jervell and Lange-Nielsen syndrome patients. Among presumed LQT5 patients, the mean QTc on presenting ECG was significantly longer in probands (476.9±38.6 ms) compared with genotype positive family members (441.8±30.9 ms, P<0.001). ECG penetrance for heterozygous genotype positive family members was 20.7% (29/140). A definite arrhythmic event was experienced in 16.9% (15/89) of heterozygous probands in comparison with 1.4% (2/140) of family members (adjusted hazard ratio [HR] 11.6 [95% CI, 2.6-52.2]; P=0.001). Event incidence did not differ significantly for Type 2 Jervell and Lange-Nielsen syndrome patients relative to the overall heterozygous cohort (10.5% [2/19]; HR 1.7 [95% CI, 0.3-10.8], P=0.590). The cumulative prevalence of the 32 KCNE1 variants in the Genome Aggregation Database, which is a human database of exome and genome sequencing data from now over 140 000 individuals, was 238-fold greater than the anticipated prevalence of all LQT5 combined (0.238% vs 0.001%).
CONCLUSIONS: The present study suggests that putative/confirmed loss-of-function KCNE1 variants predispose to QT prolongation, however, the low ECG penetrance observed suggests they do not manifest clinically in the majority of individuals, aligning with the mild phenotype observed for Type 2 Jervell and Lange-Nielsen syndrome patients.

Entities:  

Keywords:  arrhythmia; genetics; long QT syndrome; penetrance; sudden cardiac death

Mesh:

Substances:

Year:  2020        PMID: 31941373      PMCID: PMC7035205          DOI: 10.1161/CIRCULATIONAHA.119.043114

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  35 in total

Review 1.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.

Authors:  Silvia G Priori; Arthur A Wilde; Minoru Horie; Yongkeun Cho; Elijah R Behr; Charles Berul; Nico Blom; Josep Brugada; Chern-En Chiang; Heikki Huikuri; Prince Kannankeril; Andrew Krahn; Antoine Leenhardt; Arthur Moss; Peter J Schwartz; Wataru Shimizu; Gordon Tomaselli; Cynthia Tracy
Journal:  Heart Rhythm       Date:  2013-08-30       Impact factor: 6.343

2.  Long QT syndrome type 5-Lite: Defining the clinical phenotype associated with the potentially proarrhythmic p.Asp85Asn-KCNE1 common genetic variant.

Authors:  Conor M Lane; John R Giudicessi; Dan Ye; David J Tester; Ram K Rohatgi; J Martijn Bos; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2018-04-03       Impact factor: 6.343

3.  Genetic causes of sudden cardiac death in the young.

Authors:  Andrea Mazzanti; Riccardo Maragna; Silvia G Priori
Journal:  Curr Opin Cardiol       Date:  2017-03-06       Impact factor: 2.161

Review 4.  The KCNE2 K⁺ channel regulatory subunit: Ubiquitous influence, complex pathobiology.

Authors:  Geoffrey W Abbott
Journal:  Gene       Date:  2015-06-27       Impact factor: 3.688

5.  Loss-of-Function KCNE2 Variants: True Monogenic Culprits of Long-QT Syndrome or Proarrhythmic Variants Requiring Secondary Provocation?

Authors:  Jason D Roberts; Andrew D Krahn; Michael J Ackerman; Ram K Rohatgi; Arthur J Moss; Babak Nazer; Rafik Tadros; Brenda Gerull; Shubhayan Sanatani; Yanushi D Wijeyeratne; Alban-Elouen Baruteau; Alison R Muir; Benjamin Pang; Julia Cadrin-Tourigny; Mario Talajic; Lena Rivard; David J Tester; Taylor Liu; Isaac R Whitman; Julianne Wojciak; Susan Conacher; Lorne J Gula; Peter Leong-Sit; Jaimie Manlucu; Martin S Green; Robert Hamilton; Jeff S Healey; Coeli M Lopes; Elijah R Behr; Arthur A Wilde; Michael H Gollob; Melvin M Scheinman
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-08

6.  Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.

Authors:  Peter Weeke; Jonathan D Mosley; David Hanna; Jessica T Delaney; Christian Shaffer; Quinn S Wells; Sara Van Driest; Jason H Karnes; Christie Ingram; Yan Guo; Yu Shyr; Kris Norris; Prince J Kannankeril; Andrea H Ramirez; Joshua D Smith; Elaine R Mardis; Deborah Nickerson; Alfred L George; Dan M Roden
Journal:  J Am Coll Cardiol       Date:  2014-02-19       Impact factor: 24.094

7.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

8.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.

Authors:  M E Curran; I Splawski; K W Timothy; G M Vincent; E D Green; M T Keating
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

9.  Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome.

Authors:  L Bianchi; Z Shen; A T Dennis; S G Priori; C Napolitano; E Ronchetti; R Bryskin; P J Schwartz; A M Brown
Journal:  Hum Mol Genet       Date:  1999-08       Impact factor: 6.150

10.  An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome.

Authors:  Arnon Adler; Valeria Novelli; Ahmad S Amin; Emanuela Abiusi; Melanie Care; Eline A Nannenberg; Harriet Feilotter; Simona Amenta; Daniela Mazza; Hennie Bikker; Amy C Sturm; John Garcia; Michael J Ackerman; Raymond E Hershberger; Marco V Perez; Wojciech Zareba; James S Ware; Arthur A M Wilde; Michael H Gollob
Journal:  Circulation       Date:  2020-01-27       Impact factor: 29.690

View more
  7 in total

1.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Back Sternick Eduardo; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong-Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti Mac Intyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Pablo Ochoa Juan; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  J Arrhythm       Date:  2022-05-31

Review 2.  The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease.

Authors:  Mengru Wang; Xin Tu
Journal:  Front Cardiovasc Med       Date:  2022-06-15

3.  Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.

Authors:  Andrew M Glazer; Giovanni Davogustto; Christian M Shaffer; Carlos G Vanoye; Reshma R Desai; Eric H Farber-Eger; Ozan Dikilitas; Ning Shang; Jennifer A Pacheco; Tao Yang; Ayesha Muhammad; Jonathan D Mosley; Sara L Van Driest; Quinn S Wells; Lauren Lee Shaffer; Olivia R Kalash; Yuko Wada; Sarah Bland; Zachary T Yoneda; Devyn W Mitchell; Brett M Kroncke; Iftikhar J Kullo; Gail P Jarvik; Adam S Gordon; Eric B Larson; Teri A Manolio; Tooraj Mirshahi; Jonathan Z Luo; Daniel Schaid; Bahram Namjou; Tarek Alsaied; Rajbir Singh; Ashutosh Singhal; Cong Liu; Chunhua Weng; George Hripcsak; James D Ralston; Elizabeth M McNally; Wendy K Chung; David S Carrell; Kathleen A Leppig; Hakon Hakonarson; Patrick Sleiman; Sunghwan Sohn; Joseph Glessner; Joshua Denny; Wei-Qi Wei; Alfred L George; M Benjamin Shoemaker; Dan M Roden
Journal:  Circulation       Date:  2021-12-21       Impact factor: 39.918

4.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Eduardo Back Sternick; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti MacIntyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Juan Pablo Ochoa; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

5.  The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network.

Authors:  Brianna Davies; Jason D Roberts; Rafik Tadros; Martin S Green; Jeffrey S Healey; Christopher S Simpson; Shubhayan Sanatani; Christian Steinberg; Ciorsti MacIntyre; Paul Angaran; Henry Duff; Robert Hamilton; Laura Arbour; Richard Leather; Colette Seifer; Anne Fournier; Joseph Atallah; Shane Kimber; Bhavanesh Makanjee; Wael Alqarawi; Julia Cadrin-Tourigny; Jacqueline Joza; Jimmy McKinney; Stephanie Clarke; Zachary W M Laksman; Karen Gibbs; Vuk Vuksanovic; Martin Gardner; Mario Talajic; Andrew D Krahn
Journal:  CJC Open       Date:  2020-05-29

6.  Rare Coding Variants Associated With Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis.

Authors:  Seung Hoan Choi; Sean J Jurgens; Christopher M Haggerty; Amelia W Hall; Jennifer L Halford; Valerie N Morrill; Lu-Chen Weng; Braxton Lagerman; Tooraj Mirshahi; Mary Pettinger; Xiuqing Guo; Henry J Lin; Alvaro Alonso; Elsayed Z Soliman; Jelena Kornej; Honghuang Lin; Arden Moscati; Girish N Nadkarni; Jennifer A Brody; Kerri L Wiggins; Brian E Cade; Jiwon Lee; Christina Austin-Tse; Tom Blackwell; Mark D Chaffin; Christina J-Y Lee; Heidi L Rehm; Carolina Roselli; Susan Redline; Braxton D Mitchell; Nona Sotoodehnia; Bruce M Psaty; Susan R Heckbert; Ruth J F Loos; Ramachandran S Vasan; Emelia J Benjamin; Adolfo Correa; Eric Boerwinkle; Dan E Arking; Jerome I Rotter; Stephen S Rich; Eric A Whitsel; Marco Perez; Charles Kooperberg; Brandon K Fornwalt; Kathryn L Lunetta; Patrick T Ellinor; Steven A Lubitz
Journal:  Circ Genom Precis Med       Date:  2021-07-28

7.  Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome.

Authors:  Najim Lahrouchi; Rafik Tadros; Lia Crotti; Yuka Mizusawa; Pieter G Postema; Leander Beekman; Roddy Walsh; Kanae Hasegawa; Julien Barc; Marko Ernsting; Kari L Turkowski; Andrea Mazzanti; Britt M Beckmann; Keiko Shimamoto; Ulla-Britt Diamant; Yanushi D Wijeyeratne; Yu Kucho; Tomas Robyns; Taisuke Ishikawa; Elena Arbelo; Michael Christiansen; Annika Winbo; Reza Jabbari; Steven A Lubitz; Johannes Steinfurt; Boris Rudic; Bart Loeys; M Ben Shoemaker; Peter E Weeke; Ryan Pfeiffer; Brianna Davies; Antoine Andorin; Nynke Hofman; Federica Dagradi; Matteo Pedrazzini; David J Tester; J Martijn Bos; Georgia Sarquella-Brugada; Óscar Campuzano; Pyotr G Platonov; Birgit Stallmeyer; Sven Zumhagen; Eline A Nannenberg; Jan H Veldink; Leonard H van den Berg; Ammar Al-Chalabi; Christopher E Shaw; Pamela J Shaw; Karen E Morrison; Peter M Andersen; Martina Müller-Nurasyid; Daniele Cusi; Cristina Barlassina; Pilar Galan; Mark Lathrop; Markus Munter; Thomas Werge; Marta Ribasés; Tin Aung; Chiea C Khor; Mineo Ozaki; Peter Lichtner; Thomas Meitinger; J Peter van Tintelen; Yvonne Hoedemaekers; Isabelle Denjoy; Antoine Leenhardt; Carlo Napolitano; Wataru Shimizu; Jean-Jacques Schott; Jean-Baptiste Gourraud; Takeru Makiyama; Seiko Ohno; Hideki Itoh; Andrew D Krahn; Charles Antzelevitch; Dan M Roden; Johan Saenen; Martin Borggrefe; Katja E Odening; Patrick T Ellinor; Jacob Tfelt-Hansen; Jonathan R Skinner; Maarten P van den Berg; Morten Salling Olesen; Josep Brugada; Ramón Brugada; Naomasa Makita; Jeroen Breckpot; Masao Yoshinaga; Elijah R Behr; Annika Rydberg; Takeshi Aiba; Stefan Kääb; Silvia G Priori; Pascale Guicheney; Hanno L Tan; Christopher Newton-Cheh; Michael J Ackerman; Peter J Schwartz; Eric Schulze-Bahr; Vincent Probst; Minoru Horie; Arthur A Wilde; Michael W T Tanck; Connie R Bezzina
Journal:  Circulation       Date:  2020-05-20       Impact factor: 39.918

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.